Incentive Payments-Statement 24

  • Patients admitted to hospitals were and still are subjected to protocols driven by incentive payments for all things related to COVID-19 through the CARES Act, insurance incentives, and the threat of being fired. 
  • The use of remdesivir continues to have deadly outcomes. 
Exhibit 353 “How To” Guide for Health Plan Premium Incentives for the COVID-19 Vaccine (pdf) Download
Exhibit 356 The Cares Act (pdf) Download
Exhibit 359 A Randomized, Controlled Trial of Therapeutics-Remdesivir (pdf) Download
Exhibit 360 Kidney disorders-remdesivir (pdf) Download
Exhibit 361 New COVID-19 Treatments Add-On Payment (NCTAP) _ CMS (pdf) Download
Exhibit 362 WHO advises against use of remdesivir for covid-19 (pdf) Download
Exhibit 369 Federal Awards-$11 million-Am. College of Ob-Gyns (pdf) Download
Exhibit 371 Remdesivir ‘Disastrous’-Govt Pays Hospitals To Use It (pdf) Download
Exhibit 374 Attorney breaks ‘immunity defense’-Remdesivir wrongful death case (pdf) Download
Exhibit 392 Why Are Hospitals Spending So Much On Ineffective C-19 Treatments (pdf) Download
Exhibit 394 Remdesivir, the Killer Drug May Have Caused the Deaths of 100,000 Americans (pdf) Download
Exhibit 402 The Hospital Protocol Killed Their Loved Ones and They Want Justice (pdf) Download
Scroll to Top